Patents by Inventor Eric Marcotulli

Eric Marcotulli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF SYNTHESIZING NICOTINAMIDE RIBOSIDE
    Publication number: 20230348521
    Abstract: Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.
    Type: Application
    Filed: April 5, 2023
    Publication date: November 2, 2023
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris, Rajesh Thamatam
  • Methods of synthesizing nicotinamide riboside
    Patent number: 11629163
    Abstract: Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.
    Type: Grant
    Filed: June 29, 2018
    Date of Patent: April 18, 2023
    Assignee: Elysium Health, Inc.
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris, Rajesh Thamatam
  • CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE
    Publication number: 20230063175
    Abstract: Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.
    Type: Application
    Filed: August 12, 2022
    Publication date: March 2, 2023
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS
    Publication number: 20220362233
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Application
    Filed: July 25, 2022
    Publication date: November 17, 2022
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE
    Publication number: 20220305040
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: June 16, 2022
    Publication date: September 29, 2022
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric A. Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
  • Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
    Patent number: 11426398
    Abstract: Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: August 30, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Paul M. Bowen
  • Crystalline forms of nicotinamide riboside chloride
    Patent number: 11414407
    Abstract: Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.
    Type: Grant
    Filed: December 20, 2018
    Date of Patent: August 16, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • Nicotinamide riboside for use in treating or preventing liver damage
    Patent number: 11389468
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: March 16, 2018
    Date of Patent: July 19, 2022
    Assignee: Elysium Health, Inc.
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric Marcotulli, Daniel A. Alminana, Mark Morris, Leonard Pershing Guarente
  • Treating and preventing kidney damage
    Patent number: 11129843
    Abstract: Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: September 28, 2021
    Assignee: Elysium Health, Inc.
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Leonard Pershing Guarente, Ryan Dellinger, Mark Morris
  • NICOTINAMIDE RIBOSIDE FOR USE IN TREATING OR PREVENTING LIVER DAMAGE
    Publication number: 20210205342
    Abstract: Provided herein are methods and compositions related to treating and/or preventing liver related diseases and disorders and for improving liver health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: March 16, 2018
    Publication date: July 8, 2021
    Inventors: Ryan Dellinger, Santiago Roel Santos, Eric Marcotulli, Dan Alminana, Mark Morris, Leonard Pershing Guarente
  • METHODS AND COMPOSITIONS FOR TREATING MULTIPLE SCLEROSIS
    Publication number: 20210186996
    Abstract: Provided herein are methods and compositions related to treating and/or preventing multiple sclerosis in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: November 30, 2018
    Publication date: June 24, 2021
    Inventors: Eric Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • METHODS AND COMPOSITIONS FOR TREATING CHILDHOOD OR TEEN OBESITY
    Publication number: 20210177875
    Abstract: Provided herein are methods and compositions related to treating and/or preventing obesity and/or conditions associated with obesity in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: November 30, 2018
    Publication date: June 17, 2021
    Inventors: Eric Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • CRYSTALLINE FORMS OF NICOTINAMIDE RIBOSIDE CHLORIDE
    Publication number: 20210094936
    Abstract: Provided herein are crystalline forms of nicotinamide riboside chloride and methods of making the same. Also provided are compositions comprising the crystalline form of nicotinamide riboside chloride, and therapeutic methods employing the crystalline form of nicotinamide riboside chloride.
    Type: Application
    Filed: December 20, 2018
    Publication date: April 1, 2021
    Inventors: Eric Marcotulli, Dan Almknana, Ryan Dellinger, Mark Norris
  • METHODS AND COMPOSITIONS FOR TREATING GLAUCOMA
    Publication number: 20200384004
    Abstract: Provided herein are methods and compositions related to treating and/or preventing glaucoma in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: November 30, 2018
    Publication date: December 10, 2020
    Inventors: Eric Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • PREVENTION AND TREATMENT OF TDP-43 ASSOCIATED DISEASES
    Publication number: 20200330497
    Abstract: Provided herein are methods and compositions related to treating and/or preventing diseases or disorder associated with cytoplasmic accumulation of TDB-43 by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: October 19, 2018
    Publication date: October 22, 2020
    Inventors: Eric A. Marcotulli, Dan Alminana, Mark Morris, Ryan Dellinger
  • METHODS AND COMPOSITIONS FOR TREATING PREMATURE AGING DISEASES
    Publication number: 20200330496
    Abstract: Provided herein are methods and compositions related to treating and/or preventing premature aging diseases and/or progeroid syndromes in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: October 5, 2018
    Publication date: October 22, 2020
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • METHODS AND COMPOSITIONS FOR TREATING CYSTIC FIBROSIS
    Publication number: 20200261483
    Abstract: Provided herein are methods and compositions related to treating and/or preventing cystic fibrosis in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: October 29, 2018
    Publication date: August 20, 2020
    Inventors: Eric Marcotulli, Daniel Alminana, Ryan Dellinger, Mark Morris
  • METHODS OF SYNTHESIZING NICOTINAMIDE RIBOSIDE
    Publication number: 20200140475
    Abstract: Provided herein are efficient and scalable methods for the synthesis of nicotinamide riboside from riboside triacetate. Also provided are compositions comprising nicotinamide riboside, and therapeutic methods employing nicotinamide riboside.
    Type: Application
    Filed: June 29, 2018
    Publication date: May 7, 2020
    Inventors: Eric Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris, Rajesh Thamatam
  • METHODS AND COMPOSITIONS FOR IMPROVING SLEEP
    Publication number: 20200085849
    Abstract: Provided herein are methods and compositions related to treating and/or preventing sleep disorders and for improving sleep health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: May 18, 2018
    Publication date: March 19, 2020
    Inventors: Eric A. Marcotulli, Dan Alminana, Ryan Dellinger, Mark Morris
  • TREATING AND PREVENTING KIDNEY DAMAGE
    Publication number: 20200069711
    Abstract: Provided herein are methods and compositions related to treating and/or preventing kidney related diseases and disorders, treating and/or preventing acute kidney injury, and for improving kidney health in a subject by administering to the subject (e.g., orally administering to the subject) a composition comprising nicotinamide riboside and/or pterostilbene.
    Type: Application
    Filed: April 23, 2018
    Publication date: March 5, 2020
    Inventors: Eric A. Marcotulli, Daniel A. Alminana, Leonard Pershing Guarente, Ryan Dellinger, Mark Morris